Carmona L - Search Results

1

Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis.

Loza E, Lajas C, Andreu JL, Balsa A, González-Álvaro I, Illera O, Jover JÁ, Mateo I, Orte J, Rivera J, Rodríguez Heredia JM, Romero F, Martínez-López JA, Ortiz AM, Toledano E, Villaverde V, Carmona L, Castañeda S. Loza E, et al. Among authors: carmona l. Rheumatol Int. 2015 Mar;35(3):445-58. doi: 10.1007/s00296-014-3196-7. Epub 2014 Dec 28. Rheumatol Int. 2015. PMID: 25543267 Review.

2

Aceclofenac, a new nonsteroidal antiinflammatory drug, decreases the expression and function of some adhesion molecules on human neutrophils.

González-Alvaro I, Carmona L, Díaz-González F, González-Amaro R, Mollinedo F, Sánchez-Madrid F, Laffón A, García-Vicuña R. González-Alvaro I, et al. Among authors: carmona l. J Rheumatol. 1996 Apr;23(4):723-9. J Rheumatol. 1996. PMID: 8730134

3

Reduction of bone mass in women after bone marrow transplantation.

Castañeda S, Carmona L, Carvajal I, Arranz R, Díaz A, García-Vadillo A. Castañeda S, et al. Among authors: carmona l. Calcif Tissue Int. 1997 Apr;60(4):343-7. doi: 10.1007/s002239900240. Calcif Tissue Int. 1997. PMID: 9075630

4

The prevalence of rheumatoid arthritis in the general population of Spain.

Carmona L, Villaverde V, Hernández-García C, Ballina J, Gabriel R, Laffon A; EPISER Study Group. Carmona L, et al. Rheumatology (Oxford). 2002 Jan;41(1):88-95. doi: 10.1093/rheumatology/41.1.88. Rheumatology (Oxford). 2002. PMID: 11792885

5

Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study.

Lajas C, Abasolo L, Bellajdel B, Hernández-García C, Carmona L, Vargas E, Lázaro P, Jover JA. Lajas C, et al. Among authors: carmona l. Arthritis Rheum. 2003 Feb 15;49(1):64-70. doi: 10.1002/art.10905. Arthritis Rheum. 2003. PMID: 12579595 Free article.

6

Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis.

Gonzalez-Alvaro I, Carmona L, Balsa A, Sanmarti R, Belmonte MA, Tena X; EMECAR Study Group. Gonzalez-Alvaro I, et al. Among authors: carmona l. J Rheumatol. 2003 Apr;30(4):697-704. J Rheumatol. 2003. PMID: 12672186

7

Increased risk of tuberculosis in patients with rheumatoid arthritis.

Carmona L, Hernández-García C, Vadillo C, Pato E, Balsa A, González-Alvaro I, Belmonte MA, Tena X, Sanmartí R; EMECAR Study Group. Carmona L, et al. J Rheumatol. 2003 Jul;30(7):1436-9. J Rheumatol. 2003. PMID: 12858438

8

Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity.

Carmona L, González-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmartí R. Carmona L, et al. Ann Rheum Dis. 2003 Sep;62(9):897-900. doi: 10.1136/ard.62.9.897. Ann Rheum Dis. 2003. PMID: 12922967 Free PMC article.

9

Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis.

Balsa A, Carmona L, González-Alvaro I, Belmonte MA, Tena X, Sanmartí R; EMECAR Study Group. Balsa A, et al. Among authors: carmona l. J Rheumatol. 2004 Jan;31(1):40-6. J Rheumatol. 2004. PMID: 14705217

10

Prevalence of silent amyloidosis in RA and its clinical significance.

Sanmartí R, Gómez-Casanovas E, Solé M, Cañete J, Gratacós J, Carmona L, Gonzalez-Alvaro I, Muñoz-Gómez J. Sanmartí R, et al. Among authors: carmona l. J Rheumatol. 2004 May;31(5):1013-4; author reply 1014. J Rheumatol. 2004. PMID: 15124276 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

429 results

Search Page